DNTH
Dianthus Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Marino Garcia
IPO Date
2018-06-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Dianthus Therapeutics, Inc.
CEO
Marino Garcia
IPO Date
2018-06-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 16,771 |
| $80.34 |
| 18 Jun 2026 | Veness Adam M | SVP, General Counsel and Sec. | S-Sale | Disposed | 13,229 | $81.38 |
| 18 Jun 2026 | Veness Adam M | SVP, General Counsel and Sec. | M-Exempt | Disposed | 30,000 | $17.88 |
| 2 Jun 2026 | Randhawa Simrat | EVP, Head of R&D | M-Exempt | Acquired | 3,998 | $8.44 |
| 2 Jun 2026 | Randhawa Simrat | EVP, Head of R&D | M-Exempt | Acquired | 6,908 | $17.88 |
| 2 Jun 2026 | Randhawa Simrat | EVP, Head of R&D | M-Exempt | Acquired | 6,249 | $21.77 |
| 2 Jun 2026 | Randhawa Simrat | EVP, Head of R&D | M-Exempt | Acquired | 9,375 | $22.07 |
| 2 Jun 2026 | Randhawa Simrat | EVP, Head of R&D | S-Sale | Disposed | 5,428 | $89.72 |
| 2 Jun 2026 | Randhawa Simrat | EVP, Head of R&D | S-Sale | Disposed | 16,943 | $90.72 |